Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs dexmedetomidine to reduce propofol dose in BIS-guided anesthesia for femur fracture surgery
IRCT20141009019470N103Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in femoral fracture comparing Melatonin + propofol arm with Dexmedetomidine + propofol arm (2 arms). Primary endpoints: Propofol dose requirements during induction of anesthesia and Propofol dose requirements during maintenance of anesthesia. Started Feb 2021; status: completed.
02
Drugs
melatonindexmedetomidinepropofol
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20141009019470N103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N103.